Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 2/20 | 0.32 |
| ▸ | FLT3 | P36888 | 2/20 | 0.31 |
| ▸ | BMX | P51813 | 1/20 | 0.31 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.30 |
| ▸ | TUBB | P07437 | 1/20 | 0.30 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.30 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.30 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.30 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.30 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.30 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.30 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.30 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.30 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.30 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.30 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.30 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.30 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21716222 | 0.96 | GSR (0.33) | GSRFLT3BMX | |
| SCHEMBL23471978 | 0.96 | GSR (0.33) | GSRFLT3BMXTUBB4ATUBB | |
| SCHEMBL23471977 | 0.95 | GSR (0.34) | GSRFLT3BMXTUBB4ATUBB | |
| SCHEMBL23471684 | 0.93 | KDM4E (0.33) | GSR | |
| SCHEMBL21716973 | 0.92 | GSR (0.32) | GSR | |
| SCHEMBL23183846 | 0.92 | HPGD (0.33) | GSRFLT3BMXTUBB4ATUBB | |
| SCHEMBL21717057 | 0.91 | TUBB4A (0.34) | GSRFLT3BMXTUBB4ATUBB | |
| SCHEMBL21716202 | 0.91 | TUBB4A (0.34) | GSRFLT3BMXTUBB4ATUBB | |
| SCHEMBL21716226 | 0.91 | CYP1A2 (0.32) | GSR | |
| SCHEMBL21716231 | 0.91 | CYP1A2 (0.32) | GSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220029107-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2022-01-27 | — | — | US | disclosed |
| US-20210359223-A1 | ORGANIC LIGHT-EMITTING ELEMENT | LG CHEM, LTD. (KR) | 2021-11-18 | — | — | US | disclosed |
| EP-3832745-A1 | ORGANIC LIGHT-EMITTING ELEMENT | LG Chem, Ltd. (KR) | 2021-06-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210359223-A1 | ORGANIC LIGHT-EMITTING ELEMENT | LAS1L, ARL1, NAP1L4 | GSR 3942/4885FLT3 4078/4885BMX 4562/4885 |
| US-20220029107-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | CRY1, CYP1A1, CYP1B1 | GSR 3388/4885FLT3 2150/4885BMX 4351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.